ROXANA NEYRA, M.D.
Nephrology Physician in PHOENIX, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ROXANA NEYRA, M.D. filed 1,129 Medicare Part D claims in 2023 as a Nephrology Physician in PHOENIX, Arizona, prescribing 55% generic.
- 1K
- Part D claims, 2023
- 55%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ROXANA NEYRA, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,129 Top 23% higher than 77% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
ROXANA NEYRA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about ROXANA NEYRA, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Arizona
How Nephrology Physician compares to other specialties among Arizona providers
Nephrology Physician share within Arizona
Nephrology Physician is one of the more visible NUCC categories in Arizona
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Nephrology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Nephrology Physician ABMS/AOA estimate
Est. board-certified rate (Nephrology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Nephrology Physician US NPIs
Specialty board-certified rate — Nephrology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ROXANA NEYRA, M.D. appears in the CMS NPPES registry as a Nephrology Physician provider holding M.D. credentials at 3320 N 2ND ST, PHOENIX, AZ, 85012, with a listed phone of (602) 200-8288. NPI 1235132895 was issued on 05/27/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NEYRA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,129 prescription claims written by this provider, covering 132 Medicare beneficiaries and totaling roughly $600K in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Nephrology Physician is a mid-sized specialty nationwide, with 10,534 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1235132895 |
|---|---|
| Specialty | Nephrology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/27/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ROXANA NEYRA, M.D.'s current license status, disciplinary history, and board certifications with the Arizona Medical Board in Arizona before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where ROXANA NEYRA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROXANA NEYRA, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$171
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
45% brand-name claims vs 55% generic, on 1,129 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,820
- Total Day Supply
- 53,567
- Brand vs Generic
- 45% brand / 55% generic
- Brand Drug Cost
- $522K
- Generic Drug Cost
- $77K
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 69.1 years
- Avg HCC Risk Score
- 5.64
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 37, 65-74: 46, 75-84: 37, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ROXANA NEYRA, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Kerendia
Kerendia
142 claims
- Sevelamer Carbonate
Sevelamer Carbonate
122 claims
- Lokelma
Lokelma
82 claims
- Farxiga
Farxiga
76 claims
- Velphoro
Velphoro
72 claims
- Amlodipine Besylate 48
Amlodipine Besylate
48 claims
- Allopurinol 37
Allopurinol
37 claims
- Jardiance 37
Jardiance
37 claims
| Drug | Claims |
|---|---|
| Kerendia Finerenone | 142 |
| Sevelamer Carbonate | 122 |
| Lokelma Sodium Zirconium Cyclosilicate | 82 |
| Farxiga Dapagliflozin Propanediol | 76 |
| Velphoro Sucroferric Oxyhydroxide | 72 |
| Amlodipine Besylate | 48 |
| Allopurinol | 37 |
| Jardiance Empagliflozin | 37 |
| Lanthanum Carbonate | 33 |
| Spironolactone | 32 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nephrology Physician Overview
How ROXANA NEYRA, M.D. fits within the Nephrology Physician landscape nationally.
ROXANA NEYRA, M.D.'s 1,129 claims are below the specialty average of 1,454.
Nearby Nephrology Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as NEYRA.
Compare Nephrology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arizona
Frequently Asked Questions
What is ROXANA NEYRA, M.D.'s specialty? ▼
How much does ROXANA NEYRA, M.D. prescribe under Medicare Part D? ▼
Where is ROXANA NEYRA, M.D. located? ▼
What is ROXANA NEYRA, M.D.'s NPI number? ▼
Does ROXANA NEYRA, M.D. prescribe more brand-name or generic drugs? ▼
How many Nephrology Physician providers are there in the US? ▼
What drugs does ROXANA NEYRA, M.D. prescribe most often? ▼
Does ROXANA NEYRA, M.D. accept Medicare? ▼
How can I verify ROXANA NEYRA, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology